MMSI Earnings

MMSI reported its earnings on 2026-04-30, showcasing a revenue of 381.88M against an estimate of 377.50M, resulting in a 1.16% surprise. The EPS was 0.85, surpassing the expected 0.83 by 2.41%. The stock experienced a -9.05% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following MMSI's earnings announcement on 2026-04-30, the stock price moved by -9.05% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, MMSI's stock price tends to shift by an average of 0.64% in the 10 days leading up to earnings and -0.26% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate MMSI's annual revenue to reach 406.14M, while the EPS is projected at 1.05. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between MMSI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, MMSI's stock price typically moves by 0.64% in the 10 days before its earnings and -0.26% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 1.05 and revenue of 406.14M.

The earnings call summary indicates strong financial performance, with revenue and EPS exceeding guidance. The Q&A highlights positive market expansion, particularly in the breast cancer market, and strong gross margins. The divestiture of low-margin products and strategic focus on high-growth areas are positives. While geopolitical and supply chain issues are noted, they are not seen as materially impactful. The lack of new partnerships or shareholder return plans is offset by optimistic guidance and market opportunities, leading to a positive sentiment prediction for the stock price.